Primary study · included by 1 review
Sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis.
Xu 2024 · Xu B, Kang B, Li S, et al. · Journal of endocrinological investigation · 2024
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Risk of bladder cancer With sodium-glucose transporter-2 inhibitors vs Without sodium-glucose transporter-2 inhibitors | RR 0.93 [0.71, 1.21] | 6 studies · 87218 participants | Moderate |
Risk of bladder cancer Statins vs Placebo | RR 0.89 [0.68, 1.16] | 4 studies · 27849 participants | Moderate |
1 including review in total.